Introduction
The recent 15% drop in orders for Color's hereditary cancer test over the past month is a concerning trend that requires immediate attention and thorough analysis. As we delve into this issue, we'll employ a systematic approach to identify potential root causes, validate our hypotheses, and develop both short-term and long-term solutions to address the decline in test orders.
This analysis follows a structured approach covering issue identification, hypothesis generation, validation, and solution development.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Seasonal fluctuations could explain the decrease without indicating a larger problem. Expected answer: Yes, it has been compared, and this drop is unusual for this time of year. Impact on approach: If seasonal, we'd focus on year-over-year trends; if not, we'd investigate recent changes.
Why it matters: Technical glitches could be preventing orders from being placed or tracked correctly. Expected answer: No major changes have been implemented recently. Impact on approach: If changes occurred, we'd prioritize technical investigations; if not, we'd look more at market factors.
Why it matters: Changes in financial accessibility could significantly impact order volumes. Expected answer: No significant changes in insurance policies have been reported. Impact on approach: If policy changes occurred, we'd focus on pricing and accessibility; if not, we'd explore other market factors.
Why it matters: Identifying affected segments could point to specific issues or changing needs. Expected answer: The drop seems to be more significant among younger users. Impact on approach: If segment-specific, we'd tailor our investigation and solutions to that group; if uniform, we'd look at broader factors.
Practice similar questions
Subscribe to access the full answer